YIH
VIR icon

Y-Intercept (HK)’s Vir Biotechnology VIR Stock Holding History

Y-Intercept (HK)’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Buy
214,529
+79,982
+59% +$761K 0.04% 648
2026
Q1 		$1.21M Buy
+134,547
New +$1.07M 0.02% 945
2025
Q2 		– Sell
-26,073
Closed -$169K – 2051
2025
Q1 		$169K Buy
+26,073
New +$232K 0.01% 1077
2024
Q4 		– Sell
-22,455
Closed -$168K – 1691
2024
Q3 		$168K Sell
22,455
-81,494
-78% -$708K 0.01% 1187
2024
Q2 		$925K Buy
103,949
+85,629
+467% +$821K 0.05% 525
2024
Q1 		$186K Buy
+18,320
New +$187K 0.01% 1176
2023
Q4 		– Sell
-42,266
Closed -$396K – 1675
2023
Q3 		$396K Buy
+42,266
New +$603K 0.04% 651
2023
Q2 		– Sell
-38,473
Closed -$895K – 1752
2023
Q1 		$895K Buy
38,473
+3,836
+11% +$98.1K 0.1% 289
2022
Q4 		$877K Buy
+34,637
New +$849K 0.13% 241
2022
Q3 		– Sell
-12,354
Closed -$315K – 1290
2022
Q2 		$315K Buy
+12,354
New +$288K 0.04% 566

Other funds holding VIR

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FG
Foster Group West Des Moines, Iowa $3.76B AUM 21.29% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Y-Intercept (HK)'s VIR Position: Q2 2026 in Review

Y-Intercept (HK) increased its Vir Biotechnology (VIR) stake by 59% in Q2 2026, buying an estimated $761K and bringing the position to 214,529 shares worth $2.19M. The position accounts for 0.04% of the portfolio, ranked #648.

Y-Intercept (HK) first reported a position in VIR in Q2 2022 and has held it in 10 quarters since. 14 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Y-Intercept (HK) held 214,529 shares of Vir Biotechnology worth $2.19M as of Q2 2026.
  • Y-Intercept (HK) bought 79,982 Vir Biotechnology shares in Q2 2026, an estimated $761K.
  • Vir Biotechnology made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #648 holding.
  • Y-Intercept (HK) first reported a position in Vir Biotechnology in Q2 2022 and has held it in 10 quarters since.
  • 14 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.